According to reports from Essential Business Intelligence, Ramco Cements delivered strong headline financial results for Q4 FY26, with revenue rising 8.9% year-on-year to ₹2,610 crore and net profit jumping to ₹151 crore from ₹27.4 crore. The company's EBITDA climbed 16.1% to ₹370.6 crore with margins improving to 14.2% versus 13.3% in the previous year. However, when excluding a one-time gain of ₹74.2 crore, the underlying operational performance reveals concerning trends. The latest quarterly performance shows net sales reaching an all-time quarterly high of ₹2,610.32 crores with 23.97% sequential growth and 8.89% year-on-year expansion, though this masks a 60.92% quarter-on-quarter decline from the exceptional ₹385.59 crores achieved in Q3 FY26.
As reported by Essential Business Intelligence, Ramco Cements has experienced cement volume growth of just 4% year-on-year, which came in below industry growth rates. This marks the fifth consecutive quarter of market share loss and represents the second consecutive fiscal year of declining market position. The company's EBITDA per tonne of ₹670 fell short of analyst estimates of ₹750, marking the lowest profitability among peers in the 20-50 million tonne per annum capacity bracket. The five-year EBIT CAGR of -9.07% confirms that operating profit generation has actually declined over the medium term despite top-line expansion, highlighting persistent structural challenges in the competitive cement industry.
According to Essential Business Intelligence, unit variable costs rose 4% on both year-on-year and quarter-on-quarter basis, with analysts attributing pressure to higher usage of low-calorific coal versus pet coke and elevated lead distances. This cost inflation has outpaced industry peers, contributing to the company's operational challenges despite revenue growth. The interest expense declined to ₹95.23 crores from ₹108.00 crores quarter-on-quarter, indicating some deleveraging progress or refinancing benefits, though the absolute interest burden remains elevated given the company's debt-to-EBITDA ratio of 3.33 times.
As reported by Essential Business Intelligence, multiple brokerages have responded negatively to the results, with Emkay downgrading the stock to Sell from Reduce and cutting its target price to ₹725 from ₹900. The brokerage slashed FY27 and FY28 EBITDA estimates by 17% and 10% respectively and flagged upside risk to an already elevated net debt-to-EBITDA ratio of 2.5x that may delay planned capital expenditure. Elara cut its target to ₹953 from ₹1,146, citing insufficient price hikes to cover cost increases, while JM Financial maintained Reduce with a trimmed target of ₹940 from ₹990. The company's trailing P/E ratio of 115.09x represents a significant premium to the sector average and vastly exceeds the multiples accorded to higher-quality competitors with superior return profiles.
The stock has declined 7.56% over the past year and remains in a confirmed bearish technical trend since April 22, 2026, trading below all key moving averages. As per Essential Business Intelligence, the company's proprietary Mojo Score of 26/100 and 'Strong Sell' rating reflect these structural headwinds, though recent positive financial trends and stable institutional holdings of 40.34% provide some counterbalance. The dividend yield of just 0.22% provides minimal income support, reflecting constrained free cash flow generation and conservative payout policy, with management retaining the vast majority of earnings for reinvestment. The current valuation metrics signal a stock trading at unjustifiable premium levels relative to both historical norms and peer benchmarks, with investors paying nearly three times annual revenues for the business.
